The first novel influenza A (H1N1) fatality despite antiviral treatment and extracorporeal membrane oxygenation in Hong Kong

We report the first fatality caused by novel influenza A (H1N1) infection despite having the diagnosis confirmed and being given antiviral treatment after hospitalisation. This patient was also the first with influenza A (H1N1) to be supported with extracorporeal membrane oxygenation in Hong Kong. A...

Full description

Saved in:
Bibliographic Details
Published inHong Kong medical journal = Xianggang yi xue za zhi Vol. 15; no. 5; pp. 381 - 384
Main Authors Liong, T, Lee, K L, Poon, Y S, Lam, S Y, Chan, C P, Yue, C S, Chu, C M, Yuen, K Y, Law, K I
Format Journal Article
LanguageEnglish
Published China Hong Kong Academy of Medicine 01.10.2009
Subjects
Adult
Antiviral Agents - therapeutic use
Combined Modality Therapy
Extracorporeal Membrane Oxygenation - methods
Fatal Outcome
Female
Hong Kong
Humans
Influenza A Virus, H1N1 Subtype - isolation & purification
Influenza, Human - complications
Influenza, Human - therapy
Hong Kong
Online AccessGet full text

Cover

More Information
Summary:We report the first fatality caused by novel influenza A (H1N1) infection despite having the diagnosis confirmed and being given antiviral treatment after hospitalisation. This patient was also the first with influenza A (H1N1) to be supported with extracorporeal membrane oxygenation in Hong Kong. Although extracorporeal membrane oxygenation is an effective means of supporting patients with refractory hypoxaemia on high mechanical ventilatory support, it is labour-intensive and technically demanding. We also discuss the challenges faced when managing this case.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:1024-2708
2226-8707